DBV Technologies sells $30 million of shares through ATM program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025 5:02 PM EDTChâtillon, France, October 6, 2025
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies (Euronext: DBV ISIN: FR0010417345 Nasdaq Capital Market: DBVT) (the Company), a clinical-stage biopharmaceutical company, today announced that, pursuant to the Companys At-The-Market program established on September 5, 2025 (the ATM Program), it has agreed to issue and sell new ordinary shares (the Ordinary Shares) in the form of American Depositary Shares (ADSs), for total gross proceeds to the Company of approximately $30 million, before deducting sales agent commissions... More



